Bellerophon Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 8.3yrs |
Recent management updates
Recent updates
CEO
Bellerophon Therapeutics has no CEO, or we have no data on them.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Chairman of the Board | 8.3yrs | US$83.10k | 2% $ 12.7k | |
Independent Director | 7.7yrs | US$97.40k | 0.012% $ 75.7 | |
Independent Director | 8.4yrs | US$84.90k | 0.010% $ 64.8 |
8.3yrs
Average Tenure
61yo
Average Age
Experienced Board: 6L7A's board of directors are considered experienced (8.3 years average tenure).